Momenta Pharmaceuticals, Inc. - News/Events - Press Releases

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004

12/01/2014

Momenta Pharmaceuticals' Necuparanib Receives Fast Track Designation From the FDA for the Treatment of Patients With Metastatic Pancreatic Cancer

12/01/2014

Momenta Pharmaceuticals Announces Acceptance of a Clinical Trial Application in Europe for M923, a Biosimilar Version of Humira(R)

11/24/2014

Momenta Pharmaceuticals to Webcast Presentation at 2014 Deutsche Bank BioFEST

11/06/2014

Momenta Pharmaceuticals to Webcast Presentation at Three Upcoming Investor Conferences

11/05/2014

Momenta Pharmaceuticals Reports Third Quarter 2014 Financial Results

10/22/2014

Momenta Pharmaceuticals Announces Date of Third Quarter 2014 Financial Results Conference Call and Webcast

10/09/2014

Momenta Pharmaceuticals Announces Top-Line Part A Results From Phase 1/2 Trial of Necuparanib in Patients With Pancreatic Cancer

10/02/2014

Momenta Pharmaceuticals to Host 2014 R&D Day

09/17/2014

Momenta Pharmaceuticals to Webcast Presentation at BioCentury's NewsMakers in the Biotech Industry Conference

09/08/2014

Momenta Pharmaceuticals Exercises Option to Acquire Novel Antibodies From AnaptysBio

08/28/2014

Momenta Pharmaceuticals Announces Abbreviated New Drug Application for Three-Times-a-Week Generic Copaxone Accepted for Review by FDA

07/31/2014

Momenta Pharmaceuticals Reports Second Quarter 2014 Financial Results

07/30/2014

Momenta Pharmaceuticals to Webcast Presentation at the Canaccord Genuity Growth Conference

07/15/2014

Momenta Pharmaceuticals Announces Date of Second Quarter 2014 Financial Results Conference Call and Webcast

06/09/2014

Momenta Pharmaceuticals to Webcast Presentation at the Wells Fargo Healthcare Conference

06/05/2014

Momenta Pharmaceuticals Receives Orphan Drug Designation for Necuparanib (Formerly M402) in Pancreatic Cancer

05/06/2014

Momenta Pharmaceuticals Reports First Quarter 2014 Financial Results

05/02/2014

Momenta Pharmaceuticals Announces Presentation of Data Supporting Sialylation Platform

04/30/2014

Momenta Pharmaceuticals to Webcast Presentation at Three Upcoming Investor Conferences

04/15/2014

Momenta Pharmaceuticals Announces Date of First Quarter 2014 Financial Results Conference Call and Webcast

02/24/2014

Momenta Pharmaceuticals to Webcast Presentation at the Cowen and Company 34th Annual Health Care Conference

02/10/2014

Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2013 Financial Results

02/05/2014

Momenta Pharmaceuticals to Webcast Presentation at the 2014 Leerink Global Healthcare Conference

01/21/2014

Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2013 Financial Results Conference Call and Webcast